Case–control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis

[1]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[2]  K. Wiley,et al.  Ethnic Differences in DNA Methyltransferases Expression in Patients with Systemic Lupus Erythematosus , 2012, Journal of Clinical Immunology.

[3]  Hong Yang,et al.  Importance of HLA-G expression and tumor infiltrating lymphocytes in molecular subtypes of breast cancer. , 2012, Human immunology.

[4]  A. Lin,et al.  Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression. , 2012, Human immunology.

[5]  Guido Marcucci,et al.  Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  G. Zografos,et al.  Soluble human leukocyte antigen-G expression in patients with ductal and lobular breast malignancy. , 2012, Anticancer research.

[7]  J. Seidman,et al.  Brazilian urban population genetic structure reveals a high degree of admixture , 2011, European Journal of Human Genetics.

[8]  M. Bravo,et al.  Altered HLA Class I and HLA-G Expression Is Associated with IL-10 Expression in Patients with Cervical Cancer , 2011, Pathobiology.

[9]  N. Rouas-Freiss,et al.  The HLA-G non classical MHC class I molecule is expressed in cancer with poor prognosis. Implications in tumour escape from immune system and clinical applications , 2011 .

[10]  E. Donadi,et al.  A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution. , 2011, Molecular biology and evolution.

[11]  Wenfu Zhou,et al.  Human leukocyte antigen‐G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma , 2011, International journal of cancer.

[12]  S. Yie,et al.  Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer. , 2011, Tissue antigens.

[13]  Wei Li,et al.  Human leukocyte antigen‐G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells , 2011, Cancer science.

[14]  A. Bird,et al.  CpG islands and the regulation of transcription. , 2011, Genes & development.

[15]  W. Quint,et al.  Prevalence of Human Papillomavirus Infection and Associated Risk Factors in Young Women in Brazil, Canada, and the United States: A Multicenter Cross-sectional Study , 2011, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[16]  L. Du,et al.  Up-regulation of HLA-G expression in cervical premalignant and malignant lesions. , 2011, Tissue antigens.

[17]  Wei Li,et al.  Serum sHLA‐G levels: A useful indicator in distinguishing colorectal cancer from benign colorectal diseases , 2011, International journal of cancer.

[18]  N. Rouas-Freiss,et al.  The role of HLA-G in immunity and hematopoiesis , 2011, Cellular and Molecular Life Sciences.

[19]  B. Seliger,et al.  Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention? , 2011, Cellular and Molecular Life Sciences.

[20]  H. Putter,et al.  HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients , 2010, The Journal of Immunology.

[21]  G. A. Silva,et al.  Cervical HPV infection in Brazil: systematic review. , 2010, Revista de saude publica.

[22]  Gulnar Azevedo e Silva,et al.  Prevalencia de infección de cuello de útero por HPV en Brasil: revisión sistemática , 2010 .

[23]  S. Yie,et al.  Human Leukocyte Antigen-G (HLA-G) Expression in Cervical Lesions: Association With Cancer Progression, HPV 16/18 Infection, and Host Immune Response , 2010, Reproductive Sciences.

[24]  M. Schuler,et al.  Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients. , 2010, Human immunology.

[25]  Hong Yang,et al.  HLA-G Expression in Human Breast Cancer: Implications for Diagnosis and Prognosis, and Effect on Allocytotoxic Lymphocyte Response After Hormone Treatment In Vitro , 2010, Annals of Surgical Oncology.

[26]  W. Quint,et al.  High genotyping concordance between the digene HPV Genotyping RH Test and the Reverse Line Blot genotyping assay on GP5+/6+-PCR products. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[27]  Sunghoon Kim,et al.  Correlation of Human Leukocyte Antigen-G (HLA-G) Expression and Disease Progression in Epithelial Ovarian Cancer , 2009, Reproductive Sciences.

[28]  J. S. Hunt,et al.  HLA-G: a human pregnancy-related immunomodulator. , 2009, Current opinion in pharmacology.

[29]  C. Tremblay,et al.  Persistence of high levels of blood soluble human leukocyte antigen-G is associated with rapid progression of HIV infection , 2009, AIDS.

[30]  J. Kónya,et al.  Epigenetic alterations in cervical carcinogenesis. , 2009, Seminars in cancer biology.

[31]  K. Straif,et al.  A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.

[32]  J. Chies,et al.  Tolerance versus immune response -- microRNAs as important elements in the regulation of the HLA-G gene expression. , 2009, Transplant immunology.

[33]  M. Sherman,et al.  Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. , 2009, Gynecologic oncology.

[34]  C. Muñoz-Almagro,et al.  Identification of vaccine human papillomavirus genotypes in squamous intraepithelial lesions (CIN2-3). , 2008, Gynecologic oncology.

[35]  Z. Obermeyer,et al.  Coverage of Cervical Cancer Screening in 57 Countries: Low Average Levels and Large Inequalities , 2008, PLoS medicine.

[36]  H. Hausen.  Papillomaviruses—to vaccination and beyond , 2008, Biochemistry (Moscow).

[37]  Lilya V. Matyunina,et al.  Epigenetic changes within the promoter region of the HLA-G gene in ovarian tumors , 2008, Molecular Cancer.

[38]  N. Rouas-Freiss,et al.  Beyond the increasing complexity of the immunomodulatory HLA-G molecule. , 2008, Blood.

[39]  Jason D. Wright,et al.  Natural history of established low grade cervical intraepithelial (CIN 1) lesions. , 2008, Anticancer research.

[40]  N. Rouas-Freiss,et al.  NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G , 2008, Leukemia.

[41]  J. T. Cox,et al.  An Analysis of High-Risk Human Papillomavirus DNA-Negative Cervical Precancers in the ASCUS-LSIL Triage Study (ALTS) , 2008, Obstetrics and gynecology.

[42]  T. Rafnar,et al.  HPV genotypes in CIN 2‐3 lesions and cervical cancer: A population‐based study , 2007, International journal of cancer.

[43]  Hong Yang,et al.  Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. , 2007, American journal of clinical pathology.

[44]  N. Rouas-Freiss,et al.  Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses. , 2007, Seminars in cancer biology.

[45]  B. Seliger,et al.  Structure, expression and function of HLA-G in renal cell carcinoma. , 2007, Seminars in cancer biology.

[46]  S. Wagner,et al.  HLA-G expression in malignant melanoma. , 2007, Seminars in cancer biology.

[47]  Hong Yang,et al.  Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. , 2007, Lung cancer.

[48]  Hong Yang,et al.  Expression of Human Leukocyte Antigen G (HLA-G) Correlates with Poor Prognosis in Gastric Carcinoma , 2007, Annals of Surgical Oncology.

[49]  B. Seliger.  Immune Escape Mechanisms of Renal Cell Carcinoma , 2007 .

[50]  J. McCluskey,et al.  Structural studies on HLA-G: implications for ligand and receptor binding. , 2007, Human immunology.

[51]  T. Kouzarides,et al.  Viral oncoproteins target the DNA methyltransferases , 2007, Oncogene.

[52]  Hong Yang,et al.  Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer , 2007, Modern Pathology.

[53]  K. Poláková,et al.  Modulation of HLA-G expression. , 2007, Neoplasma.

[54]  A. Castelo,et al.  Primary screening for cervical cancer through self sampling , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[55]  S. Natsugoe,et al.  HLA-G expression in gastric cancer. , 2006, Anticancer research.

[56]  B. Torbett,et al.  The Class I HLA Repertoire of Pancreatic Islets Comprises the Nonclassical Class Ib Antigen HLA-G , 2006, Diabetes.

[57]  Weiguo Lu,et al.  Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma. , 2006, Life sciences.

[58]  S. Franceschi,et al.  Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis , 2005, The Lancet.

[59]  E. Carosella,et al.  HLA‐G up‐regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  P. de Cremoux,et al.  Regression of Low-Grade Cervical Intraepithelial Neoplasia in Patients With HLA-DRB1*13 Genotype , 2004, Obstetrics and gynecology.

[61]  D. Wallwiener,et al.  Detection and Typing of Human Papillomavirus by E6 Nested Multiplex PCR , 2004, Journal of Clinical Microbiology.

[62]  B. Seliger,et al.  Altered expression of nonclassical HLA class Ib antigens in human renal cell carcinoma and its association with impaired immune response. , 2003, Human immunology.

[63]  P. Moreau,et al.  Expression of HLA-G in human cornea, an immune-privileged tissue. , 2003, Human immunology.

[64]  J. T. Cox,et al.  Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. , 2003, American journal of obstetrics and gynecology.

[65]  P. Snijders,et al.  GP5+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High-Throughput Identification of Human Papillomavirus Genotypes , 2002, Journal of Clinical Microbiology.

[66]  A. Hildesheim,et al.  Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[67]  Leila Mohammadi,et al.  BMC Cancer , 2001 .

[68]  G. Russ,et al.  Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted. , 2000, Neoplasma.

[69]  A. Hongo,et al.  Analysis by Multiplex PCR of the Physical Status of Human Papillomavirus Type 16 DNA in Cervical Cancers , 1999, Journal of Clinical Microbiology.

[70]  Lydia P. Howell,et al.  NATURAL HISTORY OF CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS: A META‐ANALYSIS , 1998, Obstetrics and gynecology.

[71]  J. Dausset,et al.  HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[72]  S. Fisher,et al.  Identification of a Thymic Epithelial Cell Subset Sharing Expression of the Class Ib HLA-G Molecule with Fetal Trophoblasts , 1997, The Journal of experimental medicine.

[73]  A. Östör,et al.  Natural history of cervical intraepithelial neoplasia: a critical review. , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[74]  A. Östör,et al.  Natural history of cervical intraepithelial neoplasia: a critical review. , 1993, International Journal of Gynecological Pathology.

[75]  S. Fisher,et al.  A class I antigen, HLA-G, expressed in human trophoblasts. , 1990, Science.

[76]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.